RVP

Drug Catalog - Product Detail

IRON SUPPLEMENT/VIT C/VITB-12/STOMACH CONC. (HEMATOGEN) GELCAP MULTI 10X10 UD

NDC Mfr Size Str Form
63044-0631-19 NNODUM CORPORATION 100 NA CAPSULE
Product Image

PACKAGE FILES

Package Image
Generic Name
FERROUS FUMARATE, ASCORBIC ACID, INTRINSIC FACTOR , CYANOCOBALAMIN
Substance Name
ASCORBIC ACID
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Application Number
Description
How Supplied
HOW SUPPLIED: Each Red soft gelatin capsule is imprinted with "Ziks631" on one side. NDC 63044-0631-19 10 x 10, unit dose packs, in packs of 100's. Store at controlled between temperature 15°- 30°C (59°- 86°F). Protect from direct / excessive heat 40°C (104°F). Avoid freezing. 1 BIBLIOGRAPHY: Berk, M.S. and Novich, M.A.: 'Treatment of Iron Deficiency Anemia With Ferrous 2 Fumarate," Am. J. Obst. & Gynec., 203-206, 1962. Shapleigh, J.B., and Montgomery, A.; Am. Pract. & 3 Dig. Treat. 10-461, 1959. Brise, H. and Hallberg, L.: "Effect of Ascorbic Acid on Iron Absorption," Acta. 4 5 Med. Scand. 171 :376, 51 -58,1962. New Drugs, p. 309, AMA, Chicago, 1966. Mazur, A., Green, S. and Carleton, A.: "Mechanism of Plasma Iron Incorporation into Hepatic Ferritin," J. of Bio. Chem. 6 3:595-603, 1960. Greenberg, S.M., Tucker, A.E., Mathues, H. and J.D.: "Iron Absorption and 7 Metabolism, I. Interrelationship of Ascorbic Acid and Vitamin E," J. Nutrition 63:19-31, 1957. Moore, C. V., and Dubach, R.: "Observations on the Absorption of Iron From Foods Tagged with Radioiron, 8 "Trans. Assoc. Amer. Physic. 64:245, 1951. Steinkamp, R., Dubach, R. and Moore, C.Y. "Studies in 9 Iron Transportation and Metabolism," Arch. Int. Med. 95:181, 1955. Gorten, M.K. and Bradley, J.E.: "The Treatment of Nutritional Anemia in Infancy and Childhood with Oral Iron and Ascorbic l0 Acid,"J. Pediatrics, 45: 1, 1954. Mazur, A.: "Role of Ascorbic Acid in the Incorporation of Plasma Iron 11 into Ferritin." An. N.Y. Acad. Sci. 92:223-229, 1961. COX, E. V. et al.: "The Anemia of Scurvy," Amer. J. 12 Med. 42:220-227, 1967. Berk, L. et al.: "Observations on the Etiologic Relationship of Achylia 13 Gastrica to Pernicious Anemia, X," N. Eng. J. Med. 239:911-913, 1948. Hall, B.E.: "Studies on the 14 Nature of the Intrinsic Factor of Castle," Brit. Med. J. 2:585-589,1950. Wallerstein, R.O. et al.: "Observations on the Etiologic Relationship of Achylia Gastrica to Pernicious Anemia, XV" J. Lab 15 & Clin. Med. 41 :363-375, 1953. Castle, W.B.: "Observations on the Etiologic Relationship of Achylia 16 Gastrica to Pernicious Anemia, 1," Am. J. Med. Sc.178:748-764, 1929.
Indications & Usage
INDICATIONS: For the treatment of all anemias responsive to oral iron therapy, such as hypochromic anemia associated with pregnancy, chronic or acute blood loss, dietary restriction, metabolic disease and post-surgical convalescence.
Dosage and Administration
DOSAGE AND ADMINISTRATION: Usual adult dose is 1 soft gelatin capsule daily.